Skip to content

About Us
News, Events & Resources

Home
Drug Discovery Solutions
- Integrated Drug Discovery
  Target Validation
  Assay Development
  Hit Identification
  Hit to Lead
  Lead Optimization
  Direct-to-Biology (D2B)
  Bioscience
  Assay Development
  Biophysical Assays
  Cell Based Assays
  Biochemical Assay Development
  Technologies
  ADME / DMPK
  In Vitro ADME / DMPK Screening
  Pharmacokinetics & Bioanalysis
  Metabolite Identification (Met ID)
  Computer-aided Drug Design
  Target Evaluation
  Virtual Screening
  Structure-based Drug Design
  Ligand-based Drug Design
  Discovery Chemistry
  Synthetic Chemistry
  Medicinal Chemistry
  Peptide Synthesis Services
  Analytical & Purification
  Chemical Development Services
  Process Development
  Impurity Synthesis
  Chemical Manufacturing
  Crystallization and Purification
  Reaction Screening
  Analytical Method Development
  Discover our drug discovery solutions.
  For more information contact us on
  
  +44 (0) 1298 816700
  
  cls-info@conceptlifesciences.com
Target Approaches
Therapeutic Areas
About Us
News, Events & Resources
Careers
Contact Us

Case Studies

You are here:

Home
Case Studies

Senescence assay development

Assay Development to Monitor Cell Senescence

medicinal chemistry case study

Medicinal Chemistry and Preclinical PR&D from Discovery Lead to Development Candidate 1

Discovery Chemistry

Medicinal Chemistry Lead Optimisation_banner

Medicinal Chemistry Lead Optimisation (LO) 1

Discovery Chemistry

About us banner

Medicinal Chemistry Hit-to-Lead (H2L) 2

Discovery Chemistry

medicinal chemistry case study

Medicinal Chemistry: Hit-to-Lead (H2L)

Discovery Chemistry

Integrated Drug Discovery Services _Banner

Medicinal Chemistry: HIT Finding

Discovery Chemistry

protac banner

NFlection: Development of NFX-179 gel

Chemical Development

Chemical Development Services Banner

Preclinical PR&D: Provision of a Robust Route for Preclinical Supply and to Facilitate Clinical Supply

Chemical Development

About us banner

Charnwood Discovery supports Carrick Therapeutics in the development of the anti-cancer therapeutic CT7001

Chemical Development

Categories

Bioscience (17)
Chemical Development (4)
Discovery Chemistry (7)
Integrated Drug Discovery (2)

Share this post:

LinkedIn

WhatsApp

Get In Touch

Call +44 (0) 1298 816700 or fill out the form below

Contact Us

"*" indicates required fields

First Name*

Last Name*

Company name*

Email*

Subject

Message

Charnwood Discovery (part of Concept Life Sciences)
Frith Knoll Road, Chapel-en-le-Frith, High Peak, SK23 0PG, United Kingdom

+44 (0) 1298 816700

cls-info@conceptlifesciences.com

Services

Integrated Drug Discovery
Bioscience
Discovery Chemistry
ADME / DMPK
Computer-aided Drug Design
Chemical Development Services

Information

About Us
- Our Team
- Partnering With Us
Contact Us
News, Blog & Events
Case Studies
Resources

Charnwood Discovery (part of Concept Life Sciences) © 2024 | Cookie Policy | Privacy Policy | Terms & Conditions

Change Cookie privacy settings | Cookie Privacy settings history | Revoke consents for cookie settings

Charnwood Discovery (part of Concept Life Sciences)
Frith Knoll Road, Chapel-en-le-Frith, High Peak, SK23 0PG, United Kingdom

+44 (0) 1298 816700

cls-info@conceptlifesciences.com

Drug discovery solutions

Integrated Drug Discovery
Bioscience
Discovery Chemistry
ADME / DMPK
Computer-aided Drug Design
Chemical Development Services

Information

About Us
- Our Team
- Partnering With Us
Contact Us
News, Blog & Events
Case Studies
Resources

Charnwood Discovery © 2024 | Cookie Policy | Privacy Policy | Terms & Conditions

Change Cookie privacy settings | Cookie Privacy settings history | Revoke consents for cookie settings

Cookie Consent Banner by Real Cookie Banner